FindMyRecallSubscribe
Class I: serious health riskTerminated

Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy Tacrolimus Recall

Tacrolimus (Brand Capsules ) 0

Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy · Berkeley, CA

Risk level
Class I
Reported by FDA
Jun 15, 2022
Recall ID
D-1168-2022
Check your lot numberHow we source this data

Summary

Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy recalled Tacrolimus starting Apr 15, 2022. The FDA classified it as Class I (serious health risk) and published enforcement report D-1168-2022 on Jun 15, 2022. Reason: Subpotent drug. Status: Terminated.

Why it was recalled

Subpotent drug

Product description

Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704

Lot numbers, UPCs & expiration codes

Lot #: 04272022@35, BUD: 7/7/2022.

Where it was sold

CA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1168-2022
Classification
Class I
Status
Terminated
Recall initiated
Apr 15, 2022
FDA report date
Jun 15, 2022
Quantity
950 mLs in 1x8 oz and 2x16 oz bottles.
Recall type
Voluntary: Firm initiated
Recalling firm
Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy

Original FDA data

Every field from FDA enforcement report D-1168-2022, exactly as published.

Show all FDA fields
City
Berkeley
State
CA
Status
Terminated
Country
United States
Event ID
90289
Address
2461 Shattuck Ave
Code information
Lot #: 04272022@35, BUD: 7/7/2022.
Postal code
94704
Report date
Jun 15, 2022
Product type
Drugs
Recall number
D-1168-2022
Classification
Class I
Recalling firm
Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy
Product quantity
950 mLs in 1x8 oz and 2x16 oz bottles.
Termination date
Nov 7, 2022
Reason for recall
Subpotent drug
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704
Distribution pattern
CA
Recall initiation date
Apr 15, 2022
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Jun 27, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1168-2022, published Jun 15, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls